TD Asset Management »

Xenon Pharmaceuticals shares owned by TD Asset Management

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by TD Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $748k 16k 46.06

More positions owned by TD Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Bank Of Montreal Cadcom (BMO)
NVIDIA Corporation (NVDA)
Canadian Pacific Kansas City (CP)
UnitedHealth (UNH)
Canadian Natl Ry (CNI)
Amazon (AMZN)
Visa Com Cl A (V)
Canadian Natural Resources (CNQ)
Enbridge (ENB)
Eli Lilly & Co. (LLY)

View all positions for TD Asset Management

Top funds holding Xenon Pharmaceuticals

venBio Select Advisor
Wellington Management Company
Commodore Capital
Paradigm Biocapital Advisors
Braidwell
First Light Asset Management
Alliancebernstein
Marshall Wace
Citadel Advisors
Perceptive Advisors
Baker Bros. Advisors
Henderson Group
BVF
Point72 Asset Management
Avidity Partners Management

View all funds holding Xenon Pharmaceuticals